Merus (MRUS)
(Delayed Data from NSDQ)
$55.23 USD
+1.04 (1.92%)
Updated Jul 29, 2024 04:00 PM ET
After-Market: $55.24 +0.01 (0.02%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Brokerage Reports
0 items in cart
Merus N.V. [MRUS]
Reports for Purchase
Showing records 161 - 176 ( 176 total )
Company: Merus N.V.
Industry: Unclassified
Week Ahead: Focus Calls
Provider: WEDBUSH SECURITIES INC.
Company: Merus N.V.
Industry: Unclassified
ASCO 2017 Abstract Roundup and Schedule for Covered Companies
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Merus N.V.
Industry: Unclassified
Reports 4Q Results, ASCO Data for ''128 Next Up, Reiterate OUTPERFORM
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Merus N.V.
Industry: Unclassified
The Week Ahead in Life Sciences - Upcoming Events for the Week of May 1
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Merus N.V.
Industry: Unclassified
The Week Ahead in Life Sciences: Upcoming Events for the Week of April 24
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Merus N.V.
Industry: Unclassified
The Week Ahead in Life Sciences: Upcoming Events for the Week of March 27
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Merus N.V.
Industry: Unclassified
The Week Ahead in Life Sciences: Upcoming Events for the Week of Feb 27
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Merus N.V.
Industry: Unclassified
The Week Ahead in Life Sciences - Upcoming Events for the Week of Feb 20
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Merus N.V.
Industry: Unclassified
The Week Ahead in Life Sciences: Upcoming Events for the Week of Feb 13
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Merus N.V.
Industry: Unclassified
The Week Ahead in Life Sciences - Upcoming Events for the Week of Jan 30
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Merus N.V.
Industry: Unclassified
The Week Ahead in Life Sciences - Upcoming Events for the Week of Jan 16
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Merus N.V.
Industry: Unclassified
MRUS and INCY to Collaborate on Up to Eleven Bispecific Programs from MRUS; Increasing Our PT to $32 (from $16)
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Merus N.V.
Industry: Unclassified
Q3 Financials; Key Breast Cancer Cohort Results Could Provide Proof of Concept; Increasing PT
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Merus N.V.
Industry: Unclassified
Q2 EPS; Interim Results for MCLA-128 in Selected Breast Cancer Patients Ahead
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Merus N.V.
Industry: Unclassified
Q1:16 EPS; Looking Ahead to Interim Data for MCLA-128 in 2H:16, Reiterate OUTPERFORM
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Merus N.V.
Industry: Unclassified
Initiating with an OUTPERFORM and $14 PT; a Next- Generation Antibody Platform Targeting Unmet Need in Cancer
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D